Texas Accident Victims - News You Can Use

Vioxx skeptic also critical of Avandia

Vioxx critic attacks Avandia over heart attack risk "An analysis linking the widely used diabetes drug Avandia to higher risk of heart attacks represents a serious blow to GlaxoSmithKline PLC and underscores how outside critics have been empowered to challenge big-selling drugs after the outcry over the withdrawn painkiller Vioxx. Glaxo rang up more than $3 billion in world-wide sales of Avandia last year. Its share price fell more than 7% after the New England Journal of Medicine released the analysis by prominent cardiologist Steven Nissen of the Cleveland Clinic, who helped raise early safety concerns about Vioxx. The analysis suggested that people on Avandia have a 43% higher chance of suffering a heart attack." Anna Wilde Mathews, Wall Street Journal 5/22/07 (Subscription Only)

Read More About Vioxx skeptic also critical of Avandia...

back to top